Form 4: Exact Sciences Executive Brian Baranick Reports Stock Transactions
SEC Form 4
EVP and GM of Precision Oncology at Exact Sciences, Brian Baranick, reports acquisition and disposal of common stock related to vesting of restricted stock units and performance share units.
Summary
- Brian Baranick, EVP and GM of Precision Oncology at Exact Sciences, filed a Form 4 detailing changes in beneficial ownership.
- On February 19, 2025, Mr. Baranick acquired 1,729 shares of common stock upon vesting of restricted stock units and disposed of 968 shares for tax withholding at $49.63 per share.
- On February 20, 2025, he acquired 4,805 shares of common stock upon settlement of a performance share unit award and disposed of 2,437 shares for tax withholding at $50.48 per share.
- Following these transactions, Mr. Baranick directly owns 15,887 shares of common stock and indirectly owns 670 shares held in a 401(k) plan.
- He also holds 63,278 vested and unvested options and restricted stock units.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports stock transactions related to executive compensation. There is no indication of positive or negative sentiment towards the company's prospects.
Positives
- The acquisition of shares through vesting of restricted stock units and settlement of performance share units indicates confidence in the company's future performance.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track management's sentiment and actions regarding their company's stock.
Stakeholder Impact
- The transactions provide transparency to shareholders regarding executive stock ownership.
Key Dates
| Date | Description |
|---|---|
| 02/19/2021 | Date of restricted stock unit award grant that vests in four equal annual installments. |
| 02/19/2025 | Acquisition of 1,729 shares upon vesting of restricted stock units; disposal of 968 shares for tax withholding. |
| 02/20/2025 | Acquisition of 4,805 shares upon settlement of performance share units; disposal of 2,437 shares for tax withholding. |
| 02/21/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.